I. Nishimoto

发表

Analysis of Gα protein recognition profiles of angiotensin II receptors using chimeric Gα proteins

H. Sasamura, M. Mifune, H. Nakaya, 2000, Molecular and Cellular Endocrinology.

A novel system that reports the G‐proteins linked to a given receptor: a study of type 3 somatostatin receptor

I. Nishimoto, K. Komatsuzaki, Y. Murayama, 1997, FEBS letters.

Insulin-like Growth Factor I Receptor Activated by a Transmembrane Mutation (*)

Katsutoshi Takahashi, I. Nishimoto, K. Yonezawa, 1995, The Journal of Biological Chemistry.

Detailed Characterization of Neuroprotection by a Rescue Factor Humanin against Various Alzheimer's Disease-Relevant Insults

I. Nishimoto, Yuko Ito, Y. Hashimoto, 2001, The Journal of Neuroscience.

Overexpression of CR/periphilin downregulates Cdc7 expression and induces S-phase arrest.

I. Nishimoto, H. Masai, K. Mizumoto, 2004, Biochemical and biophysical research communications.

Humanin and colivelin: neuronal-death-suppressing peptides for Alzheimer's disease and amyotrophic lateral sclerosis.

I. Nishimoto, Y. Hashimoto, M. Matsuoka, 2006 .

Colivelin prolongs survival of an ALS model mouse.

I. Nishimoto, M. Matsuoka, S. Aiso, 2006, Biochemical and biophysical research communications.

Neuronal Apoptosis by Apolipoprotein E4 through Low-Density Lipoprotein Receptor-Related Protein and Heterotrimeric GTPases

I. Nishimoto, Y. Murayama, Yuko Ito, 2000, The Journal of Neuroscience.

Cytoplasmic tail adaptors of alzheimer’s amyloid-β protein precursor

I. Nishimoto, M. Matsuoka, M. Kawasumi, 2004, Molecular Neurobiology.

Molecular Mechanisms for Neuronal Cell Death by Alzheimer’s Amyloid Precursor Protein-Relevant Insults

I. Nishimoto, H. Tajima, Y. Hashimoto, 2002, Neurosignals.

Molecular Cloning of Caveolin-3, a Novel Member of the Caveolin Gene Family Expressed Predominantly in Muscle (*)

H. Lodish, M. Lisanti, I. Nishimoto, 1996, The Journal of Biological Chemistry.

Ligand-dependent G Protein Coupling Function of Amyloid Transmembrane Precursor (*)

S. Takeda, I. Nishimoto, Y. Murayama, 1995, The Journal of Biological Chemistry.

Implanted cannula-mediated repetitive administration of Aβ25–35 into the mouse cerebral ventricle effectively impairs spatial working memory

I. Nishimoto, H. Tajima, T. Niikura, 2005, Behavioural Brain Research.

A humanin derivative, S14G‐HN, prevents amyloid‐β‐induced memory impairment in mice

I. Nishimoto, H. Tajima, T. Niikura, 2005, Journal of neuroscience research.

Neuronal cell apoptosis by a receptor-binding domain peptide of ApoE4, not through low-density lipoprotein receptor-related protein.

I. Nishimoto, K. Umezawa, Y. Hashimoto, 2000, Biochemical and biophysical research communications.

Multiple domains of the mouse p19ARF tumor suppressor are involved in p53-independent apoptosis.

I. Nishimoto, K. Mizumoto, H. Sudo, 2003, Biochemical and biophysical research communications.

Interferon-gamma impairs physiologic downregulation of cyclin-dependent kinase inhibitor, p27Kip1, during G1 phase progression in macrophages.

I. Nishimoto, S. Asano, M. Matsuoka, 1999, Experimental hematology.

Alzheimer amyloid protein precursor complexes with brain GTP-binding protein Go

I. Nishimoto, Y. Murayama, Shuji Takahashi, 1993, Nature.

Death and survival of neuronal cells exposed to Alzheimer's insults

I. Nishimoto, H. Tajima, Y. Hashimoto, 2002, Journal of neuroscience research.

Multiple Mechanisms Underlie Neurotoxicity by Different Types of Alzheimer's Disease Mutations of Amyloid Precursor Protein*

I. Nishimoto, Y. Hashimoto, T. Niikura, 2000, The Journal of Biological Chemistry.

The Cytoplasmic Domain of Alzheimer's Amyloid-β Protein Precursor Causes Sustained Apoptosis Signal-Regulating Kinase 1/c-Jun NH2-Terminal Kinase-Mediated Neurotoxic Signal via Dimerization

I. Nishimoto, H. Ichijo, H. Nishitoh, 2003, Journal of Pharmacology and Experimental Therapeutics.

Characterization of Amyotrophic Lateral Sclerosis-linked P56S Mutation of Vesicle-associated Membrane Protein-associated Protein B (VAPB/ALS8)*

I. Nishimoto, M. Matsuoka, S. Aiso, 2006, Journal of Biological Chemistry.

Direct control of exocytosis by receptor‐mediated activation of the heterotrimeric GTPases Gi and G(o) or by the expression of their active G alpha subunits.

I. Nishimoto, T. Okamoto, C. Wollheim, 1995, The EMBO journal.

Alsin, the Product of ALS2 Gene, Suppresses SOD1 Mutant Neurotoxicity through RhoGEF Domain by Interacting with SOD1 Mutants*

I. Nishimoto, Y. Hashimoto, T. Niikura, 2004, Journal of Biological Chemistry.

IGF-I receptor protection from apoptosis in cells lacking the IRS proteins.

I. Nishimoto, R. Baserga, M. Dews, 1997, Receptors & signal transduction.

Expression of N19S‐SOD1, an SOD1 mutant found in sporadic amyotrophic lateral sclerosis patients, induceslow‐grade motoneuronal toxicity

I. Nishimoto, Y. Hashimoto, T. Niikura, 2005, Journal of neuroscience research.

Neuroprotective effect of activity‐dependent neurotrophic factor against toxicity from familial amyotrophic lateral sclerosis‐linked mutant SOD1 in vitro and in vivo

H. Schulman, I. Nishimoto, H. Tajima, 2004, Journal of neuroscience research.

Cytotoxic mechanisms by M239V presenilin 2, a little‐analyzed Alzheimer's disease‐causative mutant

I. Nishimoto, H. Tajima, Y. Hashimoto, 2004, Journal of neuroscience research.

Neurotoxic mechanisms by Alzheimer's disease-linked N141I mutant presenilin 2.

I. Nishimoto, Yuko Ito, Y. Hashimoto, 2002, The Journal of pharmacology and experimental therapeutics.

A tripartite motif protein TRIM11 binds and destabilizes Humanin, a neuroprotective peptide against Alzheimer's disease‐relevant insults

I. Nishimoto, H. Tajima, Y. Hashimoto, 2003, The European journal of neuroscience.

Activation of a calcium-permeable cation channel by insulin-like growth factor II in BALB/c 3T3 cells.

I. Nishimoto, E. Ogata, K. Kurokawa, 1988, The American journal of physiology.

Identification, sequence, and expression of caveolin-2 defines a caveolin gene family.

H. Lodish, M. Lisanti, I. Nishimoto, 1996, Proceedings of the National Academy of Sciences of the United States of America.

Amino acids 356–372 constitute a Gi‐activator sequence of the α2‐adrenergic receptor and have a Phe substitute in the G protein‐activator sequence motif

I. Nishimoto, T. Okamoto, T. Ikezu, 1992, FEBS letters.

GTP‐binding protein‐activator sequences in the insulin receptor

I. Nishimoto, Y. Murayama, T. Okamoto, 1993, FEBS letters.

Identification of a Gs activator region of the β2-adrenergic receptor that is autoregulated via protein kinase A-dependent phosphorylation

I. Nishimoto, Y. Murayama, M. Inagaki, 1991, Cell.

Antibody-Regulated Neurotoxic Function of Cell-Surface β-Amyloid Precursor Protein

I. Nishimoto, Y. Murayama, Y. Hashimoto, 2000, Molecular and Cellular Neuroscience.

Involvement of tyrosine kinases and STAT3 in Humanin-mediated neuroprotection.

Sadakazu Aiso, Masaaki Matsuoka, I. Nishimoto, 2005, Life sciences.

Humanin and colivelin: Neuronal-death-suppressing peptides for Alzheimer’s disease

I. Nishimoto, Y. Hashimoto, M. Matsuoka, 2006, Neuropeptides.

Unravelling the role of Humanin.

I. Nishimoto, T. Niikura, M. Matsuoka, 2004, Trends in molecular medicine.

Characterization of the toxic mechanism triggered by Alzheimer's amyloid‐β peptides via p75 neurotrophin receptor in neuronal hybrid cells

I. Nishimoto, Y. Hashimoto, T. Niikura, 2003, Journal of neuroscience research.

Neurotoxic mechanisms triggered by Alzheimer's disease‐linked mutant M146L presenilin 1: involvement of NO synthase via a novel pertussis toxin target

I. Nishimoto, Yuko Ito, Y. Hashimoto, 2002, Journal of neurochemistry.

Expression of V642 APP mutant causes cellular apoptosis as Alzheimer trait‐linked phenotype.

S. Takeda, I. Nishimoto, Y. Murayama, 1996, The EMBO journal.

V642I APP-inducible neuronal cells: a model system for investigating Alzheimer's disorders.

I. Nishimoto, Y. Hashimoto, T. Niikura, 2000, Biochemical and biophysical research communications.

Evidence for in vivo production of Humanin peptide, a neuroprotective factor against Alzheimer's disease-related insults

I. Nishimoto, Yuko Ito, H. Tajima, 2002, Neuroscience Letters.

Identification of essential amino acids in Humanin, a neuroprotective factor against Alzheimer’s disease-relevant insults

I. Nishimoto, Y. Hashimoto, T. Niikura, 2003, Peptides.

Regulation of eIF-4E BP1 Phosphorylation by mTOR*

M. Kasuga, J. Avruch, I. Nishimoto, 1997, The Journal of Biological Chemistry.

Humanin: after the discovery.

I. Nishimoto, T. Niikura, M. Matsuoka, 2004, Molecular neurobiology.

Distinctive regulation of the functional linkage between the human cation-independent mannose 6-phosphate receptor and GTP-binding proteins by insulin-like growth factor II and mannose 6-phosphate.

T. Katada, I. Nishimoto, Y. Murayama, 1990, The Journal of biological chemistry.

Molecular characterization of neurohybrid cell death induced by Alzheimer's amyloid‐β peptides via p75NTR/PLAIDD

D. Bredesen, I. Nishimoto, Y. Hashimoto, 2004, Journal of neurochemistry.

Insulin-like growth factor-II/mannose 6-phosphate receptor is incapable of activating GTP-binding proteins in response to mannose 6-phosphate, but capable in response to insulin-like growth factor-II.

I. Nishimoto, Y. Murayama, E. Ogata, 1990, Biochemical and biophysical research communications.

Evidence that type II insulin-like growth factor receptor is coupled to calcium gating system.

I. Nishimoto, E. Ogata, E. Ogata, 1988, Biochemical and biophysical research communications.

Involvement of c‐Jun N‐terminal kinase in amyloid precursor protein‐mediated neuronal cell death

I. Nishimoto, A. Lin, Osahiko Tsuji, 2003, Journal of neurochemistry.

The ARF tumor suppressor inhibits BCL6-mediated transcriptional repression.

I. Nishimoto, K. Mizumoto, Hiroaki Suzuki, 2004, Biochemical and biophysical research communications.

Transforming Growth Factor (cid:2) 2 Is a Neuronal Death-Inducing Ligand for Amyloid- (cid:2) Precursor Protein

I. Nishimoto, Y. Hashimoto, Hiroaki Suzuki, 2022 .

Interaction between the Alzheimer's survival peptide humanin and insulin-like growth factor-binding protein 3 regulates cell survival and apoptosis

Pinchas Cohen, I. Nishimoto, P. Cohen, 2003, Proceedings of the National Academy of Sciences of the United States of America.

Two serine residues distinctly regulate the rescue function of Humanin, an inhibiting factor of Alzheimer's disease‐related neurotoxicity: functional potentiation by isomerization and dimerization

I. Nishimoto, H. Tajima, Y. Hashimoto, 2003, Journal of neurochemistry.

The Gtx Homeodomain Transcription Factor Exerts Neuroprotection Using Its Homeodomain*

I. Nishimoto, Osahiko Tsuji, Y. Hashimoto, 2004, Journal of Biological Chemistry.

The IGF‐II receptor system: A G protein‐linked mechanism

I. Nishimoto, 1993, Molecular reproduction and development.

Gs regulation of endosome fusion suggests a role for signal transduction pathways in endocytosis.

I. Nishimoto, E. Ross, M. Colombo, 1994, The Journal of biological chemistry.

Characterization of V642I‐AβPP‐induced cytotoxicity in primary neurons

I. Nishimoto, T. Niikura, M. Matsuoka, 2004, Journal of neuroscience research.

The cytoplasmic domain of Alzheimer’s amyloid- protein precursor causes sustained ASK1/JNK mediated neurotoxic signal via dimerization

I. Nishimoto, H. Ichijo, H. Nishitoh, 2003 .

G protein betagamma complex-mediated apoptosis by familial Alzheimer's disease mutant of APP.

I. Nishimoto, Y. Murayama, U. Giambarella, 1997, The EMBO journal.

MULTICENTRIC HEPATOCELLULAR CARCINOMA FOLLOWING PHOSPHATE DIETHYLSTILBESTROL THERAPY FOR PROSTATIC CANCER

I. Nishimoto, H. Endo, M. Yokoyama, 1987, Acta pathologica japonica.

Analysis of Neurons Created from Wild-Type and Alzheimer's Mutation Knock-In Embryonic Stem Cells by a Highly Efficient Differentiation Protocol

T. Iwatsubo, I. Nishimoto, T. Tomita, 2003, The Journal of Neuroscience.

Anti-apoptotic action of Wnt5a in dermal fibroblasts is mediated by the PKA signaling pathways.

I. Nishimoto, M. Matsuoka, S. Aiso, 2008, Cellular signalling.

A simple structure encodes G protein-activating function of the IGF-II/mannose 6-phosphate receptor

T. Katada, I. Nishimoto, Y. Murayama, 1990, Cell.

Detection of G protein-activator regions in M4 subtype muscarinic, cholinergic, and alpha 2-adrenergic receptors based upon characteristics in primary structure.

I. Nishimoto, T. Okamoto, T Okamoto, 1992, The Journal of biological chemistry.

Mechanisms of neuroprotection by a novel rescue factor humanin from Swedish mutant amyloid precursor protein.

I. Nishimoto, Y. Hashimoto, T. Niikura, 2001, Biochemical and biophysical research communications.

A rescue factor abolishing neuronal cell death by a wide spectrum of familial Alzheimer's disease genes and Aβ

G. Sobue, I. Nishimoto, H. Tajima, 2001, Proceedings of the National Academy of Sciences of the United States of America.

Neuroprotection against neurodegenerative diseases

I. Nishimoto, M. Matsuoka, S. Aiso, 2007, Molecular Neurobiology.

Targeted introduction of V642I mutation in amyloid precursor protein gene causes functional abnormality resembling early stage of Alzheimer's disease in aged mice

T. Iwatsubo, S. Kato, I. Nishimoto, 2004, The European journal of neuroscience.

A New Paradigm for Neurotoxicity by FAD Mutants of βAPP: A Signaling Abnormality

I. Nishimoto, 1998, Neurobiology of Aging.

Apoptosis in neurodegenerative diseases.

I. Nishimoto, U. Giambarella, T. Okamoto, 1997, Advances in pharmacology.

Intrinsic signaling function of APP as a novel target of three V642 mutations linked to familial Alzheimer's disease.

T. Katada, I. Nishimoto, Y. Murayama, 1996, The EMBO journal.

Differential Effect of ik3-1/Cables on p53- and p73-induced Cell Death*

I. Nishimoto, K. Mizumoto, M. Matsuoka, 2002, The Journal of Biological Chemistry.

ik3-2, a relative to ik3-1/Cables, is involved in both p53-mediated and p53-independent apoptotic pathways.

I. Nishimoto, H. Sudo, Hiroaki Suzuki, 2003, Biochemical and biophysical research communications.

Wnt5a promotes adhesion of human dermal fibroblasts by triggering a phosphatidylinositol-3 kinase/Akt signal.

I. Nishimoto, M. Matsuoka, S. Aiso, 2007, Cellular signalling.

ik3-1/Cables is associated with Trap and Pctaire2.

I. Nishimoto, M. Matsuoka, T. Yamochi, 2001, Biochemical and biophysical research communications.

Molecular cloning of a cyclin-like protein associated with cyclin-dependent kinase 3 (cdk 3) in vivo.

I. Nishimoto, K. Semba, Y. Matsuura, 2000, Biochemical and biophysical research communications.

Measurement of GTP gamma S binding to specific G proteins in membranes using G-protein antibodies.

I. Nishimoto, Y. Murayama, E. Ogata, 1992, FEBS letters.

Measurement of GTPγS binding to specific G proteins in membranes using G‐protein antibodies

I. Nishimoto, Y. Murayama, T. Okamoto, 1992 .

Possible direct linkage of insulin-like growth factor-II receptor with guanine nucleotide-binding proteins.

T. Katada, I. Nishimoto, Y. Murayama, 1989, The Journal of biological chemistry.

Evidence for a Regulated Interaction between Heterotrimeric G Proteins and Caveolin

M. Lisanti, I. Nishimoto, M. Sargiacomo, 1995, The Journal of Biological Chemistry.

Distinct mode of G protein activation due to single residue substitution of active IGF-II receptor peptide Arg2410-Lys2423: evidence for stimulation acceptor region other than C-terminus of Gi alpha.

I. Nishimoto, E. Ogata, T. Okamoto, 1991, Biochemical and biophysical research communications.

Anti-ALS Activity of Alsin, the Product of the ALS2 Gene, and Activity-Dependent Neurotrophic Factor

Masaaki Matsuoka, I. Nishimoto, M. Matsuoka, 2006, Neurodegenerative Diseases.

A Rac1/Phosphatidylinositol 3-Kinase/Akt3 Anti-apoptotic Pathway, Triggered by AlsinLF, the Product of the ALS2 Gene, Antagonizes Cu/Zn-superoxide Dismutase (SOD1) Mutant-induced Motoneuronal Cell Death*

I. Nishimoto, Y. Hashimoto, Y. Kita, 2005, Journal of Biological Chemistry.

D‐Serine is a key determinant of glutamate toxicity in amyotrophic lateral sclerosis

I. Nishimoto, K. Okamoto, M. Matsuoka, 2007, The EMBO journal.

Transforming Growth Factor (cid:2) 2 Is a Neuronal Death-Inducing Ligand for Amyloid- (cid:2) Precursor Protein

I. Nishimoto, Y. Hashimoto, Hiroaki Suzuki, 2005 .

c-Jun N-Terminal Kinase (JNK)-Interacting Protein-1b/Islet-Brain-1 Scaffolds Alzheimer's Amyloid Precursor Protein with JNK

T. Hiraki, I. Nishimoto, J. Kyriakis, 2001, The Journal of Neuroscience.

Secreted Aβ Does Not Mediate Neurotoxicity by Antibody-Stimulated Amyloid Precursor Protein

T. Hiraki, I. Nishimoto, Yuko Ito, 2001 .

Insulin-Like Growth Factor I (IGF-I) Protects Cells from Apoptosis by Alzheimer's V642I Mutant Amyloid Precursor Protein through IGF-I Receptor in an IGF-Binding Protein-Sensitive Manner

T. Hiraki, I. Nishimoto, T. Okamoto, 2001, The Journal of Neuroscience.

G protein βγ complex‐mediated apoptosis by familial Alzheimer's disease mutant of APP

I. Nishimoto, Y. Murayama, U. Giambarella, 1997 .

G Protein-Mediated Neuronal DNA Fragmentation Induced by Familial Alzheimer's Disease-Associated Mutants of APP

S. Takeda, T. Iwatsubo, I. Nishimoto, 1996, Science.

Regulation of CI− channels by multifunctional CaM kinase

H. Schulman, I. Nishimoto, J. Wagner, 1991, Neuron.

ik3-2, a relative to ik3-1/cables, is associated with cdk3, cdk5, and c-abl.

I. Nishimoto, M. Matsuoka, Hiroko Sato, 2002, Biochimica et biophysica acta.

Negative transactivation of cAMP response element by familial Alzheimer's mutants of APP.

I. Nishimoto, K. Komatsuzaki, T. Okamoto, 1996, The EMBO journal.

Somatostatin type V receptor activates c-Jun N-terminal kinases via Galpha(12) family G proteins.

I. Nishimoto, K. Komatsuzaki, T. B. Kinane, 2001, Biochemical and biophysical research communications.

Insulin-like growth factor II stimulates calcium influx in competent BALB/c 3T3 cells primed with epidermal growth factor. Characteristics of calcium influx and involvement of GTP-binding protein.

Y. Hata, I. Nishimoto, E. Ogata, 1987, The Journal of biological chemistry.

Possible requirement of serum progression factors for transformation of BALB/c 3T3 fibroblasts by v‐Ras p21

I. Nishimoto, S. Harada, 1991, FEBS letters.

Humanin inhibits neuronal cell death by interacting with a cytokine receptor complex or complexes involving CNTF receptor alpha/WSX-1/gp130.

I. Nishimoto, Y. Hashimoto, M. Matsuoka, 2009, Molecular biology of the cell.

ik3-1/Cables is a substrate for cyclin-dependent kinase 3 (cdk 3).

I. Nishimoto, K. Semba, H. Sato, 2001, European journal of biochemistry.

A Novel Transmembrane Semaphorin Can Bind c-src

M. Fishman, I. Nishimoto, K. Yonezawa, 1997, Molecular and Cellular Neuroscience.

Calcium influx: an intracellular message of the mitogenic action of insulin-like growth factor-I.

I. Nishimoto, E. Ogata, K. Kurokawa, 1988, The Journal of biological chemistry.

Multiple domains interacting with Gs in the porcine calcitonin receptor.

S. Krane, I. Nishimoto, Y. Murayama, 2000, Molecular endocrinology.

Transforming growth factor beta2 is a neuronal death-inducing ligand for amyloid-beta precursor protein.

I. Nishimoto, Y. Hashimoto, Hiroaki Suzuki, 2005, Molecular and cellular biology.

In Vivo Coupling of Insulin-like Growth Factor II/Mannose 6-Phosphate Receptor to Heteromeric G Proteins

T. Yokota, I. Nishimoto, U. Giambarella, 1995, The Journal of Biological Chemistry.

Conversion of G-protein specificity of insulin-like growth factor II/mannose 6-phosphate receptor by exchanging of a short region with beta-adrenergic receptor.

Katsutoshi Takahashi, T. Yokota, I. Nishimoto, 1993, Proceedings of the National Academy of Sciences of the United States of America.

Cell surface receptor function of amyloid precursor protein that activates Ser/Thr kinases.

I. Nishimoto, Y. Murayama, U. Giambarella, 1996, Gerontology.

Analysis of Galpha protein recognition profiles of angiotensin II receptors using chimeric Galpha proteins.

H. Sasamura, M. Mifune, H. Nakaya, 2000, Molecular and Cellular Endocrinology.

Neuroprotection Against Neurodegenerative Diseases: Development of a Novel Hybrid Neuroprotective Peptide Colivelin

I. Nishimoto, M. Matsuoka, S. Aiso, 2008, Molecular Neurobiology.

Insulin-like Growth Factor II Stimulates Calcium Influx in Competent Balb/c 3T3 Cells Primed with Epidermal Growth Factor

I. Nishimoto, E. Ogata, I. Kojima, 1989 .

Regulation of transmembrane signal transduction of insulin-like growth factor II by competence type growth factors or viral ras p21.

I. Nishimoto, E. Ogata, T. Asano, 1991, The Journal of biological chemistry.

Bidirectional regulation of c-fos promoter by an oncogenic gip2 mutant of G alpha i2. A novel implication of retinoblastoma gene product.

I. Nishimoto, Y. Murayama, E. Ogata, 1994, The Journal of biological chemistry.

Pertussis toxin inhibits the action of insulin-like growth factor-I.

I. Nishimoto, E. Ogata, I. Kojima, 1987, Biochemical and biophysical research communications.

Insulin-like growth factor II increases cytoplasmic free calcium in competent Balbc 3T3 cells treated with epidermal growth factor

I. Nishimoto, E. Ogata, I. Kojima, 1987 .

1 Characterization of Amyotrophic Lateral Sclerosis-Linked Pro 56 Ser Mutation of Vesicle-Associated Membrane Protein-Associated Protein B ( VAPB / ALS 8 )

I. Nishimoto, M. Matsuoka, S. Aiso, 2006 .

Development of a Femtomolar-Acting Humanin Derivative Named Colivelin by Attaching Activity-Dependent Neurotrophic Factor to Its N Terminus: Characterization of Colivelin-Mediated Neuroprotection against Alzheimer's Disease-Relevant Insults In Vitro and In Vivo

I. Nishimoto, Y. Hashimoto, Y. Kita, 2005, The Journal of Neuroscience.

Amino‐ and carboxyl‐terminal mutants of presenilin 1 cause neuronal cell death through distinct toxic mechanisms: Study of 27 different presenilin 1 mutants

I. Nishimoto, A. Takashima, Y. Hashimoto, 2004, Journal of neuroscience research.

Sedation and Anesthesia Mediated by Distinct GABAA Receptor Isoforms

G. Dawson, T. Iwatsubo, I. Nishimoto, 2003, The Journal of Neuroscience.

Humanin antagonists: mutants that interfere with dimerization inhibit neuroprotection by Humanin

I. Nishimoto, Y. Hashimoto, T. Niikura, 2004, The European journal of neuroscience.

Potential CRE suppression by familial Alzheimer's mutants of APP independent of adenylyl cyclase regulation

I. Nishimoto, Y. Murayama, U. Giambarella, 1997, FEBS letters.

Insulin-like growth factor II increases cytoplasmic free calcium in competent Balb/c 3T3 cells treated with epidermal growth factor.

I. Nishimoto, E. Ogata, I. Kojima, 1987, Biochemical and biophysical research communications.

Transforming growth factor β2 autocrinally mediates neuronal cell death induced by amyloid‐β

I. Nishimoto, Y. Hashimoto, M. Matsuoka, 2006 .

Transforming Growth Factor β2 Is a Neuronal Death-Inducing Ligand for Amyloid-β Precursor Protein

I. Nishimoto, Y. Hashimoto, M. Matsuoka, 2005, Molecular and Cellular Biology.

[Neuronal cell death by Alzheimer's disease-relevant insults and its rescue].

I. Nishimoto, H. Tajima, Y. Hashimoto, 2003, Nihon Ronen Igakkai zasshi. Japanese journal of geriatrics.

Transforming growth factor beta2 autocrinally mediates neuronal cell death induced by amyloid-beta.

I. Nishimoto, Y. Hashimoto, M. Matsuoka, 2006, Journal of neuroscience research.

Regulation of lymphocyte chloride channels.

H. Schulman, I. Nishimoto, T. McDonald, 1991, Advances in experimental medicine and biology.